Share on LinkedInShare on LinkedIn

ARTICLE · 25 AUGUST 2015

Protecting Diagnostic Innovation – Two Actor Infringement Liability

A patent strategy that may still protect a companion diagnostic is a "test-and-treat" type claim that links the diagnostic test and the therapeutic intervention.

United StatesIntellectual Property

In Akamai Techs. Inc. v. Limelight Networks, Inc., (August 13, 2015 Fed. Cir.) an en banc Federal Circuit unanimously held that direct infringement under Section 271(a) can occur:

”where all steps of a claimed method are performed by or attributed to a single entity…Where more than one actor is involved in practicing the steps, a court must determine whether the acts of one are attributable to the other such that a single entity is responsible for the infringement. We will hold an entity is responsible for others’ performance or method steps in two sets of circumstances: (1) where that entity directs or controls others’ performance, and (2) where the actors form a joint enterprise.” Slip Op. at 4.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from